Post by Ypsomed AG

China's pharmaceutical industry is moving the needle, both in drug delivery and in global biopharmaceutical innovation 🚀. As the country's pharmaceutical sector evolves, so do the expectations placed on device partners. Local manufacturing, local expertise, and globally recognized standards are now essential for companies developing therapies for both the Chinese and global markets 🌍. In our latest ONdrugDelivery article, our experts Orfeo Niedermann, Jackie Hong Cui and Shawn James explore how this transformation is reshaping China's drug delivery landscape and why Ypsomed has spent more than 20 years building an operating model designed to grow alongside it 💡. Read the full article on our website 👉 https://brnw.ch/21x46LS #ONdrugDelivery #PharmaInnovation #GlobalStandards #ypsomed